Smiley face
Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines Authorized As Booster For Younger Kids
Oct12

Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines Authorized As Booster For Younger Kids

US FDA News Release, Oct. 12, 2022 Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine, Bivalent and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to authorize their use as a single booster dose in younger age groups. The Moderna COVID-19 Vaccine, Bivalent is authorized for administration at least two months following completion of primary or booster vaccination...

Read More
USFDA Authorizes Second Booster Dose Of Pfizer, Moderna COVID-19 Vaccines For Ages 50 And Up And Immunocompromised Individuals
Mar29

USFDA Authorizes Second Booster Dose Of Pfizer, Moderna COVID-19 Vaccines For Ages 50 And Up And Immunocompromised Individuals

Today (March 28, 2022), the U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. The FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series. This makes a second booster dose of both vaccines available...

Read More
FDA Approves Second COVID-19 Vaccine
Jan31

FDA Approves Second COVID-19 Vaccine

News Release – Monday, Jan. 31, 2022 Moderna To Be Marketed as Spikevax COVID-19 Vaccine For Ages 18+ Today (Jan. 31, 2022), the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older.  Key points Spikevax meets the FDA’s rigorous...

Read More
COVID-19 Vaccine Clinic Time Change, Shortage Of Testing Supplies Reported For CHRISTUS Facilities
Jan25

COVID-19 Vaccine Clinic Time Change, Shortage Of Testing Supplies Reported For CHRISTUS Facilities

Holly Ragan, Senior Market Development, CHRISTUS Mother Frances Hospital – Sulphur Springs, [email protected] COVID Testing at CHRISTUS Trinity Clinics | Urgent Care COVID Test Due to a shortage of COVID testing supplies, we unfortunately cannot guarantee that rapid tests will be available. If rapid tests are not available, we will be able to send out a COVID PCR test, which typically results in 2 days, but could take up...

Read More
CHRISTUS Mother Frances Hospital – Sulphur Springs And NETX Public Health District Partner To Offer Pediatric COVID-19 Vaccines
Jan25

CHRISTUS Mother Frances Hospital – Sulphur Springs And NETX Public Health District Partner To Offer Pediatric COVID-19 Vaccines

Holly Ragan, Market Development, CHRISTUS Mother Frances Hospital – Sulphur Springs, [email protected] Sulphur Springs, Texas, January 25, 2022 – CHRISTUS Mother Frances Hospital – Sulphur Springs will be partnering with Northeast Texas Public Health District to provide COVID vaccinations for children ages 5 through 11. The vaccine clinic will be held in the MMU tent located in the parking lot north of the hospital...

Read More
FDA Shortens Interval For Booster Dose of Moderna COVID-19 Vaccine to 5 Months
Jan07

FDA Shortens Interval For Booster Dose of Moderna COVID-19 Vaccine to 5 Months

FDA News Release – Jan. 7, 2022 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Moderna COVID-19 Vaccine to shorten the time between the completion of a primary series of the vaccine and a booster dose to at least 5 months for individuals 18 years of age and older. “The country is in the middle of a wave of the highly contagious omicron variant, which spreads more rapidly than...

Read More
FDA Acts To Expand Use Of Pfizer COVID-19 Vaccine
Jan03

FDA Acts To Expand Use Of Pfizer COVID-19 Vaccine

FDA Jan. 3, 2022 News Release Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to: Expand the use of a single booster dose to include use in individuals 12 through 15 years of age.Shorten the time between the completion of primary vaccination of the Pfizer-BioNTech COVID-19 Vaccine and a booster dose to at least five months.Allow for a third primary...

Read More
FDA Expands Eligibility For COVID-19 Vaccine Booster For All Individuals 18 Or Older
Nov19

FDA Expands Eligibility For COVID-19 Vaccine Booster For All Individuals 18 Or Older

FDA News Release – November 19, 2021 Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUA) for both the Moderna and Pfizer-BioNTech COVID-19 vaccines, authorizing use of a single booster dose for all individuals 18 years of age and older after completion of primary vaccination with any FDA-authorized or approved COVID-19 vaccine. The Centers for Disease Control and Prevention’s (CDC)...

Read More
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Emergency Use In Children 5 Through 11 Years of Age
Oct29

FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Emergency Use In Children 5 Through 11 Years of Age

Friday, Oct. 29, 2021 USFDA New Release Today, the U.S. Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age. The authorization was based on the FDA’s thorough and transparent evaluation of the data that included input from independent advisory committee experts who overwhelmingly voted in favor of making the...

Read More
FDA Takes Additional Actions On Use Of A Booster Dose For COVID-19 Vaccines
Oct21

FDA Takes Additional Actions On Use Of A Booster Dose For COVID-19 Vaccines

US FDA News Release The U.S. Food and Drug Administration Wednesday, Oct. 20, took action to expand the use of a booster dose for COVID-19 vaccines in eligible populations. The agency is amending the emergency use authorizations (EUA) for COVID-19 vaccines to allow for the use of a single booster dose as follows: The use of a single booster dose of the Moderna COVID-19 Vaccine that may be administered at least 6 months after...

Read More